• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤芽生在结直肠癌中的组织病理学意义及预后影响

Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.

作者信息

Mehta Anurag, Goswami Malini, Sinha Rupal, Dogra Atika

机构信息

Department of Laboratory Services, Rajiv Gandhi Cancer Institute & Research Centre, Delhi, India.

Department of Research, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India. Email:

出版信息

Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2447-2453. doi: 10.22034/APJCP.2018.19.9.2447.

DOI:10.22034/APJCP.2018.19.9.2447
PMID:30255698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6249446/
Abstract

Background: Colorectal cancer (CRC) is a heterogeneous disease with a complex etiology. New prognostic factors need to be investigated. Our present focus is on histopathological significance and prognostic impact of tumor budding in CRC. Material and Methods: A total of 60 treatment-naive consecutive patients undergoing surgical resection of CRCs during the period of January 2011 to December 2013 were included in the study. Details of each related to their demographic and tumor profile were recorded. Hematoxylin and Eosin (H and E) and pan-cytokeratin details of each “case” immunohistochemically stained sections were examined for tumor budding assessment along with clinical features. Results: The most frequent site of involvement was the rectosigmoid and sigmoid colon (31.6%). The majority of the cases were moderately differentiated (75%), showed tumor invasion into the pericolic/subserosal fat (66.6%) and stage III (38.3%). Nodal involvement was present in 47%. Correlations between tumor budding and nodal involvement (p-value 0.039) and AJCC stage (p-value 0.021) were found to be statistically significant. Conclusion: Tumor budding is a promising and powerful predictor of lymph nodal metastasis and a higher stage of tumor and can be used as a marker for high-risk CRC. Routine H and E staining aided by cytokeratin immunostaining allows reproducible grading of tumor budding in CRC cases.

摘要

背景

结直肠癌(CRC)是一种病因复杂的异质性疾病。需要研究新的预后因素。我们目前的重点是CRC中肿瘤芽生的组织病理学意义和预后影响。

材料与方法

本研究纳入了2011年1月至2013年12月期间60例未经治疗且连续接受CRC手术切除的患者。记录了每位患者的人口统计学和肿瘤特征的详细信息。对苏木精和伊红(H&E)染色以及每个“病例”免疫组化染色切片的全细胞角蛋白细节进行检查,以评估肿瘤芽生情况,并结合临床特征进行分析。

结果

最常受累的部位是直肠乙状结肠和乙状结肠(31.6%)。大多数病例为中度分化(75%),显示肿瘤侵犯至结肠周围/浆膜下脂肪(66.6%),且处于III期(38.3%)。47%的病例存在淋巴结受累。发现肿瘤芽生与淋巴结受累(p值0.039)和美国癌症联合委员会(AJCC)分期(p值0.021)之间的相关性具有统计学意义。

结论

肿瘤芽生是淋巴结转移和肿瘤更高分期的一个有前景且有力的预测指标,可作为高危CRC的标志物。常规H&E染色辅以细胞角蛋白免疫染色可对CRC病例中的肿瘤芽生进行可重复的分级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d45/6249446/3f0ed79d6550/APJCP-19-2447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d45/6249446/162e9420cad6/APJCP-19-2447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d45/6249446/823b1c990259/APJCP-19-2447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d45/6249446/3f0ed79d6550/APJCP-19-2447-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d45/6249446/162e9420cad6/APJCP-19-2447-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d45/6249446/823b1c990259/APJCP-19-2447-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d45/6249446/3f0ed79d6550/APJCP-19-2447-g003.jpg

相似文献

1
Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.肿瘤芽生在结直肠癌中的组织病理学意义及预后影响
Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2447-2453. doi: 10.22034/APJCP.2018.19.9.2447.
2
Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.肿瘤芽生在结直肠癌中的组织病理学意义及预后影响
Ann Clin Lab Sci. 2017 Mar;47(2):129-135.
3
Tumor Budding Detection by Immunohistochemical Staining is Not Superior to Hematoxylin and Eosin Staining for Predicting Lymph Node Metastasis in pT1 Colorectal Cancer.免疫组织化学染色检测肿瘤芽殖在预测pT1期结直肠癌淋巴结转移方面并不优于苏木精和伊红染色。
Dis Colon Rectum. 2016 May;59(5):396-402. doi: 10.1097/DCR.0000000000000567.
4
Prognostic value of immunohistochemical analysis of tumor budding in colorectal carcinoma.结直肠癌中肿瘤芽生免疫组化分析的预后价值
Anticancer Res. 2008 May-Jun;28(3B):1831-6.
5
Differential clinical impacts of tumour budding evaluated by the use of immunohistochemical and haematoxylin and eosin staining in stage II colorectal cancer.肿瘤微浸润评估对Ⅱ期结直肠癌临床影响的差异:免疫组化与苏木精-伊红染色法的对比研究。
Histopathology. 2019 Jun;74(7):1005-1013. doi: 10.1111/his.13830. Epub 2019 Apr 1.
6
Comparative analysis between multilevel sectioning with conventional haematoxylin and eosin staining and immunohistochemistry for detecting nodal micrometastases with stage I and II colorectal cancers.对Ⅰ期和Ⅱ期结直肠癌采用传统苏木精-伊红染色的多层切片法与免疫组织化学法检测淋巴结微转移的对比分析。
Asian Pac J Cancer Prev. 2014;15(4):1725-30. doi: 10.7314/apjcp.2014.15.4.1725.
7
The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.肿瘤芽生在结直肠癌中的作用:肠道癌干细胞标志物Lgr5可能的参与情况。
Indian J Pathol Microbiol. 2020 Jan-Mar;63(1):32-37. doi: 10.4103/IJPM.IJPM_154_19.
8
Development of a semi-automated method for tumour budding assessment in colorectal cancer and comparison with manual methods.一种用于结直肠癌肿瘤芽评估的半自动方法的开发及其与手动方法的比较。
Histopathology. 2022 Feb;80(3):485-500. doi: 10.1111/his.14574. Epub 2021 Nov 10.
9
The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.癌症干细胞标志物(Notch1、醛脱氢酶1和CD44)在原发性结直肠癌中的预后价值
J Gastrointest Cancer. 2019 Dec;50(4):824-837. doi: 10.1007/s12029-018-0156-6.
10
Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.肿瘤周围及肿瘤内芽生在食管腺癌中的影响
Hum Pathol. 2016 Jun;52:1-8. doi: 10.1016/j.humpath.2016.01.016. Epub 2016 Feb 10.

引用本文的文献

1
Tumor Budding as a Risk Factor for Lymph Node Metastasis and Local Recurrence in pT1 Colorectal Cancer: A Systematic Review and Meta-Analysis.肿瘤芽生作为pT1期结直肠癌淋巴结转移和局部复发的危险因素:一项系统评价和荟萃分析
Gastro Hep Adv. 2025 May 27;4(9):100713. doi: 10.1016/j.gastha.2025.100713. eCollection 2025.
2
Histopathologic and Prognostic Significance of Tumor Budding in Colorectal Adenocarcinoma: A Retrospective Cohort Study Conducted in Shiraz, Iran.结直肠癌中肿瘤芽生的组织病理学及预后意义:在伊朗设拉子进行的一项回顾性队列研究
Iran J Pathol. 2024 Winter;19(1):59-66. doi: 10.30699/IJP.2023.1999329.3090. Epub 2021 Dec 15.
3

本文引用的文献

1
Tumor Budding, Micropapillary Pattern, and Polyploidy Giant Cancer Cells in Colorectal Cancer: Current Status and Future Prospects.结直肠癌中的肿瘤芽生、微乳头模式和多倍体巨癌细胞:现状与未来展望
Stem Cells Int. 2016;2016:4810734. doi: 10.1155/2016/4810734. Epub 2016 Oct 23.
2
Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.结直肠癌中肿瘤芽生影响的系统评价和荟萃分析
Br J Cancer. 2016 Sep 27;115(7):831-40. doi: 10.1038/bjc.2016.274. Epub 2016 Sep 6.
3
Cytokeratin immunohistochemistry improves interobserver variability between unskilled pathologists in the evaluation of tumor budding in T1 colorectal cancer.
A Correlation of Tumour Budding and Tumour-Stroma Ratio with Clinicopathological Factors in Oral Squamous Cell Carcinoma.
口腔鳞状细胞癌中肿瘤芽生与肿瘤-基质比率与临床病理因素的相关性
Sultan Qaboos Univ Med J. 2024 Feb;24(1):52-57. doi: 10.18295/squmj.9.2023.048. Epub 2024 Feb 28.
4
Tumor budding as a prognostic indicator in colorectal carcinoma: a retrospective study of primary colorectal carcinoma cases in a tertiary care center.肿瘤芽生作为结直肠癌的预后指标:一项对三级医疗中心原发性结直肠癌病例的回顾性研究
Indian J Surg Oncol. 2022 Sep;13(3):459-467. doi: 10.1007/s13193-022-01498-7. Epub 2022 Jan 18.
5
The prognostic value of tumor budding in laryngeal squamous cell carcinoma.肿瘤芽生在喉鳞状细胞癌中的预后价值
Transl Cancer Res. 2020 Jan;9(1):119-127. doi: 10.21037/tcr.2019.11.28.
6
Prognostic Impact of Tumor Budding on Moroccan Colon Cancer Patients.肿瘤出芽对摩洛哥结肠癌患者预后的影响。
Int J Surg Oncol. 2022 Jan 21;2022:9334570. doi: 10.1155/2022/9334570. eCollection 2022.
7
Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.胆囊癌肿瘤芽殖的预后价值:国际肿瘤芽殖共识会议评分系统的应用。
Virchows Arch. 2021 Jun;478(6):1071-1078. doi: 10.1007/s00428-020-03012-2. Epub 2021 Jan 4.
8
Analysis of Endoscopy Findings to Identify Early Gastric Cancers with Tumor Budding: A Retrospective Study.内镜检查结果分析:以肿瘤芽殖识别早期胃癌——一项回顾性研究。
J Gastrointest Surg. 2021 Jul;25(7):1706-1715. doi: 10.1007/s11605-020-04862-6. Epub 2020 Nov 9.
细胞角蛋白免疫组织化学可改善非专业病理学家在评估T1期结直肠癌肿瘤芽生时的观察者间变异性。
Pathol Int. 2016 Feb;66(2):75-82. doi: 10.1111/pin.12374. Epub 2016 Jan 11.
4
Tumour budding in colorectal cancer: what do we know and what can we do?结直肠癌中的肿瘤芽生:我们知道什么以及我们能做什么?
Virchows Arch. 2016 Apr;468(4):397-408. doi: 10.1007/s00428-015-1886-5. Epub 2015 Nov 27.
5
Tumor budding in colorectal cancer--ready for diagnostic practice?结直肠癌中的肿瘤芽生——适用于诊断实践吗?
Hum Pathol. 2016 Jan;47(1):4-19. doi: 10.1016/j.humpath.2015.08.007. Epub 2015 Sep 3.
6
Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.II期结直肠癌中的肿瘤芽生与生存:一项系统评价和汇总分析
J Gastrointest Cancer. 2015 Sep;46(3):212-8. doi: 10.1007/s12029-015-9716-1.
7
Tumour budding: a promising parameter in colorectal cancer.肿瘤芽殖:结直肠癌有前途的参数。
Br J Cancer. 2012 May 22;106(11):1713-7. doi: 10.1038/bjc.2012.127. Epub 2012 Apr 24.
8
Tumor budding in colorectal carcinomas.结直肠癌中的肿瘤芽生
Turk Patoloji Derg. 2012;28(1):61-6. doi: 10.5146/tjpath.2012.01099.
9
Assessment of tumor budding in colorectal carcinoma: correlation with β-catenin nuclear expression.结直肠癌中肿瘤芽生的评估:与β-连环蛋白核表达的相关性
J Egypt Natl Canc Inst. 2011 Mar;23(1):1-9. doi: 10.1016/j.jnci.2011.07.001. Epub 2011 Sep 8.
10
Tumor budding is a strong and reproducible prognostic marker in T3N0 colorectal cancer.肿瘤芽生是T3N0期结直肠癌中一种强有力且可重复的预后标志物。
Am J Surg Pathol. 2009 Jan;33(1):134-41. doi: 10.1097/PAS.0b013e318184cd55.